Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 53776 - 53800 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Nimesulide	Approved Investigational Withdrawn	PTGS2	5743	downregulated	nimesulide results in decreased expression of PTGS2 mRNA	1q31.1	A23343 A23338
Nimesulide	Approved Investigational Withdrawn	VEGFC	7424	downregulated	nimesulide results in decreased expression of VEGFC mRNA	4q34.3	A23344
Nimodipine	Approved Investigational	FOS	2353	upregulated	Nimodipine results in increased expression of FOS mRNA	14q24.3	A20417
Nimustine	Investigational	ABCC1	4363	upregulated	Nimustine results in increased expression of ABCC1 mRNA	16p13.11	A23345
Nimustine	Investigational	BCL2L11	10018	upregulated	Nimustine results in increased expression of BCL2L11 mRNA	2q13	A23346
Nimustine	Investigational	FASLG	356	upregulated	Nimustine results in increased expression of FASLG mRNA	1q24.3	A23346
Nimustine	Investigational	FOSL1	8061	upregulated	Nimustine results in increased expression of FOSL1 mRNA	11q13.1	A23347
Nimustine	Investigational	GCLC	2729	upregulated	Nimustine results in increased expression of GCLC mRNA	6p12.1	A23345
Nimustine	Investigational	MGMT	4255	upregulated	Nimustine results in increased expression of MGMT mRNA	10q26.3	A22171
Nimustine	Investigational	TREX1	11277	upregulated	Nimustine results in increased expression of TREX1 mRNA	3p21.31	A21557
Nimustine	Investigational	XPC	7508	upregulated	Nimustine results in increased expression of XPC mRNA	3p25.1	A23348
Nitric Oxide	Approved Investigational	BBC3	27113	upregulated	Nitric Oxide results in increased expression of BBC3 mRNA	19q13.32	A23349
Nitric Oxide	Approved Investigational	BIRC3	330	downregulated	Nitric Oxide results in decreased expression of BIRC3 mRNA	11q22.2	A23349
Nitric Oxide	Approved Investigational	BIRC5	332	downregulated	Nitric Oxide results in decreased expression of BIRC5 mRNA	17q25.3	A23349
Nitric Oxide	Approved Investigational	CDH1	999	downregulated	Nitric Oxide results in decreased expression of CDH1 mRNA	16q22.1	A23350
Nitric Oxide	Approved Investigational	DUSP1	1843	upregulated	Nitric Oxide results in increased expression of DUSP1 mRNA	5q35.1	A23351
Nitric Oxide	Approved Investigational	FAS	355	upregulated	Nitric Oxide results in increased expression of FAS mRNA	10q23.31	A23349
Nitric Oxide	Approved Investigational	HMOX1	3162	upregulated	Nitric Oxide results in increased stability of and results in increased expression of HMOX1 mRNA	22q12.3	A23351
Nitric Oxide	Approved Investigational	HSPA5	3309	downregulated	[NOS3 protein polymorphism results in decreased chemical synthesis of Nitric Oxide] which results in decreased expression of HSPA5 mRNA	9q33.3	A23352
Nitric Oxide	Approved Investigational	KDM1A	23028	upregulated	Nitric Oxide results in increased expression of KDM1A mRNA	1p36.12	A23353
Nitric Oxide	Approved Investigational	KDM3A	55818	upregulated	Nitric Oxide results in increased expression of KDM3A mRNA	2p11.2	A23353
Nitric Oxide	Approved Investigational	KDM3B	51780	upregulated	Nitric Oxide results in increased expression of KDM3B mRNA	5q31.2	A23353
Nitric Oxide	Approved Investigational	KDM4A	9682	upregulated	Nitric Oxide results in increased expression of KDM4A mRNA	1p34.2-p34.1	A23353
Nitric Oxide	Approved Investigational	KDM4B	23030	upregulated	Nitric Oxide results in increased expression of KDM4B mRNA	19p13.3	A23353
Nitric Oxide	Approved Investigational	KDM4C	23081	upregulated	Nitric Oxide results in increased expression of KDM4C mRNA	9p24.1	A23353

Displaying entries 53776 - 53800 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability